An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies
An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies
This is an open-label, multicenter, extension study to evaluate the long-term safety and efficacy of BeiGene or BeOne investigational drugs in participants with advanced malignancies who participated in a prior BeiGene- or BeOne-sponsored clinical study (parent study).
For the purposes of this study, "study treatment" will refer to all investigational agents. A parent study is defined as the original BeiGene- or BeOne-sponsored clinical trial in which the participant was initially enrolled and received BeiGene or BeOne investigational drugs (with or without other treatments).
Note: Our company, previously known as BeiGene, is now officially BeOne Medicines. Because some of our older studies were sponsored under the name BeiGene, you may see both names used for this study on this website.
Key Inclusion Criteria:
Currently participating in a BeiGene- or BeOne-sponsored eligible parent study
Fulfills treatment criteria specified in the parent study protocol
In the opinion of the investigator, the participant will continue to benefit from and tolerate any of the parent study treatments.
The first dose of study treatment in the LTE study will be received within the treatment interruption period allowed by the parent study:
Key Exclusion Criteria:
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Guangzhou, Guangdong 510030, China
Zuiyi, Guizhou 550002, China
Wuhan, Hubei 430030, China
Shanghai, Shanghai Municipality 200092, China
Hangzhou, Zhejiang 310009, China
Akitashi, Akita 010-8543, Japan
Izumishi, Osaka 594-0073, Japan
Suitashi, Osaka 565-0871, Japan
ChuoKu, Tokyo 104-0045, Japan
BundangGu SeongnamSi, Gyeonggi-do 13496, South Korea
IlsandongGu GoyangSi, Gyeonggi-do 10408, South Korea
PaldalGu SuwonSi, Gyeonggi-do 16247, South Korea
NamdongGu, Incheon Gwang'yeogsi 21565, South Korea
HwasunGun, Jeollanam-do 58128, South Korea
DongjakGu, Seoul Teugbyeolsi 07061, South Korea
GangnamGu, Seoul Teugbyeolsi 06351, South Korea
GuroGu, Seoul Teugbyeolsi 08308, South Korea
SeochoGu, Seoul Teugbyeolsi 06591, South Korea
SeodaemunGu, Seoul Teugbyeolsi 03722, South Korea
SongpaGu, Seoul Teugbyeolsi 05505, South Korea
Guishan Dist, 33305, Taiwan
Niaosong Dist, 83301, Taiwan
North Dist, 704, Taiwan
Yongkang Dist, 710, Taiwan
stanbulBakrkoy, 34147, Turkey (Türkiye)